A new study examined blood samples stored up to nine years before participants received a cancer diagnosis. The researchers found alterations in DNA that appeared to mirror the body's response to early, still-invisible tumor activity. This suggests that routine blood tests might someday spot cancer risk well before symptoms emerge.
The study, as reported by Medical Xpress, focused on changes that were not mutations in cancer cells themselves but rather shifts in the DNA's chemical marks—likely reflecting immune or inflammatory reactions. These signals were present in samples collected years prior to diagnosis, hinting that the body's response to cancer starts much earlier than previously recognized.
Because the source is a single report, there are no conflicting accounts to compare. The findings are preliminary and need validation in larger, prospective studies. Still, they offer a promising avenue for developing blood-based screening tools that could complement existing detection methods and potentially improve survival odds.